EDGAR Filing Documents for 0001654954-20-005714

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-20-005714

Filing Date

2020-05-18

Accepted

2020-05-18 15:35:07

Documents

Period of Report

2020-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	sbfm_10q.htm	10-Q	542049
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex311.htm	EX-31.1	12351
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex312.htm	EX-31.2	11986
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32	7201
5	IMAGE	sbfm_10q000.jpg	GRAPHIC	9909
6	IMAGE	sbfm_10q001.jpg	GRAPHIC	21516
7	IMAGE	sbfm_10q002.jpg	GRAPHIC	14391
8	IMAGE	sbfm_10q003.jpg	GRAPHIC	13284
9	IMAGE	sbfm_10q004.jpg	GRAPHIC	13314
	Complete submission text file	0001654954-20-005714.txt		1853565

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE DOCUMENT	sbfm-20200331.xml	EX-101.INS	189384
11	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20200331.xsd	EX-101.SCH	15471
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20200331_cal.xml	EX-101.CAL	34636
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20200331_def.xml	EX-101.DEF	38178
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20200331_lab.xml	EX-101.LAB	129486
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20200331_pre.xml	EX-101.PRE	101533

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)